Free Trial

Mind Medicine (MindMed) (MNMD) Competitors

$7.38
+0.02 (+0.27%)
(As of 06/24/2024 ET)

MNMD vs. TLRY, CRON, USNA, CGC, BTMD, ACB, CDXC, FTLF, MDWD, and BGXX

Should you be buying Mind Medicine (MindMed) stock or one of its competitors? The main competitors of Mind Medicine (MindMed) include Tilray (TLRY), Cronos Group (CRON), USANA Health Sciences (USNA), Canopy Growth (CGC), biote (BTMD), Aurora Cannabis (ACB), ChromaDex (CDXC), FitLife Brands (FTLF), MediWound (MDWD), and Bright Green (BGXX). These companies are all part of the "medicinals & botanicals" industry.

Mind Medicine (MindMed) vs.

Mind Medicine (MindMed) (NASDAQ:MNMD) and Tilray (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, community ranking, media sentiment and institutional ownership.

27.9% of Mind Medicine (MindMed) shares are owned by institutional investors. Comparatively, 9.4% of Tilray shares are owned by institutional investors. 2.3% of Mind Medicine (MindMed) shares are owned by company insiders. Comparatively, 0.7% of Tilray shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Mind Medicine (MindMed) presently has a consensus price target of $20.00, indicating a potential upside of 171.00%. Tilray has a consensus price target of $2.71, indicating a potential upside of 63.15%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher possible upside, analysts clearly believe Mind Medicine (MindMed) is more favorable than Tilray.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mind Medicine (MindMed)
0 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.11
Tilray
0 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.25

Mind Medicine (MindMed) has a net margin of 0.00% compared to Tilray's net margin of -43.98%. Tilray's return on equity of -2.68% beat Mind Medicine (MindMed)'s return on equity.

Company Net Margins Return on Equity Return on Assets
Mind Medicine (MindMed)N/A -84.72% -59.00%
Tilray -43.98%-2.68%-2.09%

Mind Medicine (MindMed) has a beta of 2.64, indicating that its share price is 164% more volatile than the S&P 500. Comparatively, Tilray has a beta of 2.25, indicating that its share price is 125% more volatile than the S&P 500.

Tilray received 406 more outperform votes than Mind Medicine (MindMed) when rated by MarketBeat users. However, 91.11% of users gave Mind Medicine (MindMed) an outperform vote while only 59.28% of users gave Tilray an outperform vote.

CompanyUnderperformOutperform
Mind Medicine (MindMed)Outperform Votes
41
91.11%
Underperform Votes
4
8.89%
TilrayOutperform Votes
447
59.28%
Underperform Votes
307
40.72%

In the previous week, Mind Medicine (MindMed) had 1 more articles in the media than Tilray. MarketBeat recorded 9 mentions for Mind Medicine (MindMed) and 8 mentions for Tilray. Mind Medicine (MindMed)'s average media sentiment score of 0.47 beat Tilray's score of 0.24 indicating that Mind Medicine (MindMed) is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mind Medicine (MindMed)
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tilray
2 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Mind Medicine (MindMed) has higher earnings, but lower revenue than Tilray. Tilray is trading at a lower price-to-earnings ratio than Mind Medicine (MindMed), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mind Medicine (MindMed)N/AN/A-$95.73M-$2.94-2.51
Tilray$627.12M2.05-$1.45B-$0.44-3.77

Summary

Mind Medicine (MindMed) beats Tilray on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MNMD vs. The Competition

MetricMind Medicine (MindMed)Medicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$518.58M$1.22B$5.09B$8.31B
Dividend YieldN/AN/A5.30%4.09%
P/E Ratio-2.519.66169.5918.09
Price / SalesN/A14.652,303.9092.79
Price / CashN/A157.0633.0831.84
Price / Book3.881.924.714.19
Net Income-$95.73M-$105.78M$108.59M$216.21M
7 Day Performance0.82%2.77%0.28%0.09%
1 Month Performance-10.33%-8.30%-3.09%-2.47%
1 Year Performance123.64%-0.50%-2.87%0.21%

Mind Medicine (MindMed) Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray
0.9882 of 5 stars
$1.69
flat
$2.71
+60.3%
+9.2%$1.31B$627.12M-3.841,600
CRON
Cronos Group
1.0205 of 5 stars
$2.33
+0.9%
$3.00
+28.8%
+27.6%$890.08M$87.24M-15.53356Gap Down
USNA
USANA Health Sciences
2.6306 of 5 stars
$45.50
+0.1%
$46.00
+1.1%
-25.3%$866.78M$921.01M14.171,800
CGC
Canopy Growth
0.5043 of 5 stars
$7.12
+0.4%
$4.87
-31.6%
+35.1%$542.54M$220.27M-1.121,029Positive News
BTMD
biote
2.1683 of 5 stars
$6.61
+0.9%
$8.11
+22.7%
+12.0%$410.08M$185.36M60.09194Analyst Revision
News Coverage
ACB
Aurora Cannabis
0.5638 of 5 stars
$5.52
-3.5%
N/A-7.7%$301.12M$174.88M-1.901,130Analyst Revision
CDXC
ChromaDex
3.6476 of 5 stars
$2.71
-1.5%
$6.00
+121.4%
+55.5%$204.71M$83.57M-54.20106
FTLF
FitLife Brands
0 of 5 stars
$29.08
+5.0%
N/A+91.1%$133.77M$52.70M19.6537Gap Down
MDWD
MediWound
0.7725 of 5 stars
$13.64
-6.5%
$32.00
+134.6%
+39.6%$126.63M$19.85M-9.88100Analyst Upgrade
News Coverage
BGXX
Bright Green
0 of 5 stars
$0.28
+3.7%
N/A-68.9%$53.59MN/A-4.035Positive News

Related Companies and Tools

This page (NASDAQ:MNMD) was last updated on 6/25/2024 by MarketBeat.com Staff

From Our Partners